Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors
NCT04094506
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
Interventions
DRUG:
ASP1948
Sponsor
Astellas Pharma Inc